Article
Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults.
Scientific reports - 22 Nov 2019
Koehne Erik, Kreidenweiss Andrea, Zoleko Manego Rella, McCall Matthew, Mombo-Ngoma Ghyslain, Mackwitz Marcel Karl Walter, Hansen Finn K, Held Jana
Abstract excerpt
Histone deacetylase (HDAC) enzymes are targets for the development of antimalarial drugs with a different mode of action to established antimalarials. Broad-spectrum HDAC-inhibitors show high potency against Plasmodium falciparum, but displayed some toxicity towards human cells. Inhibitors of human HDAC6 are new drug candidates with supposed reduced toxicity to human cells and favorable activities against...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
